Biopartnering Seminar Series - Fibrin Sealant Patch Pricing (Johnson & Johnson)

The Spartans
Tuesday, November 17, 2015 - 6:30pm
Fibrin Sealant Patch Pricing (Johnson & Johnson), The Spartans - MBiotech Student Team

Tuesday, November 17, 2015, 6:30pm.
Room 120, Instructional Building.

Our project has aimed to establish a pricing model for Johnson and Johnson’s new Evarrest fibrin sealant patch. The Evarrest fibrin sealant patch is a haemostatic patch consisting of human fibrinogen and thrombin embedded in oxidized regenerated cellulose. It has been indicated for use during adult liver and soft-tissue surgery as an adjunct to traditional methods to control bleeding. By assessing the haemostat market we have determined four essential criteria that must be considered in our pricing model: competition, customer, company and market trends. We have established a proof-of-concept model that utilizes historical sales and pricing data of haemostats to illustrate how we predict the market will respond to Evarrest and how it’s pricing will be impacted.

Further, we have established a thorough sensitivity analysis that gauges the low and high extremes of our pricing model in order to confidently predict a range of expected revenues and sales volumes. Finally, we will recommend a sales strategy that leverages high profit margins and brand loyalty from other haemostats in Johnson and Johnson’s portfolio to support a strong launch for Evarrest. 

This seminar will be open to the public.

This seminar is part of the Biopartnering Seminar Series, offered by the Master of Biotechnology Program.